Chat with Filing

Ask questions about this document

Please log in or register to use the chat feature. Please register first.

RPA - Circio invites to R&D and corporate update webcast on 28 May 2025

Company: Circio Holding ASA Date: 2025-05-22 Language: English Register to download

Loading document preview...

Document Preview Not Available

The file type (.html) cannot be displayed directly here.

Open Original File

Error loading document preview. Please try the 'Open Original File' link.

You're One Click Away From The Full Filing

Instantly access this document—and 2.8M more—for free. Select your preferred method:

Continue with Google Continue with Microsoft Continue with Facebook Continue with Amazon

 Circio invites to R&D and corporate update webcast on 28 May 2025

# Circio invites to R&D and corporate update webcast on 28 May 2025

· CTO Dr. Thomas B Hansen will present a summary of recent in vivo results  

validating circVec performance in novel AAV and DNA formats for gene and cell  

therapy  

· CEO Dr. Erik D Wiklund will provide a corporate and business development  

update, incl.  information related to the upcoming annual general meeting  

  

Oslo, Norway 22 May 2025 - Circio Holding ASA (OSE: CRNA), a biotechnology  

company developing powerful circular RNA technology for next generation nucleic  

acid medicine, invites to a live webcast at 10:00am CEST on Wednesday 28 May  

2025.  

  

In the webcast, CTO Dr. Thomas B Hansen will present Circio´s latest circVec  

platform in vivo results. Recent findings include validation of the circVec  

platform using novel AAV and DNA vector formats, and demonstrate enhanced and  

distinct tissue expression profiles vs. equivalent conventional mRNA-based  

vectors. The results highlight potential applications for circVec in tissue  

targeted gene therapy and in vivo cell therapy; a field that is advancing  

rapidly and gaining strong momentum in the industry.  

  

CEO Dr. Erik D Wiklund will provide a corporate update including business  

development activities and background and practical information relating to  

proposals for shareholder approval at the annual general meeting to be held on 5  

June 2025.  

  

Presenters:  

CEO Dr. Erik Digman Wiklund  

CTO Dr. Thomas Birkballe Hansen  

  

Time: 10:00 CEST on 28 May 2025  

  

Click here to access Teams  

webcast (https://teams.microsoft.com/meet/3919530790393?p=D2tS9HOrDxAFf5WhLj)  

Meeting ID: 391 953 079 039 3  

Passcode: PB2gk7wt  

  

Questions can be submitted in advance by email to Erik D Wiklund:  

erik.wiklund@circio.com or directly in the live webcast  

  

A recording of the webcast will be made available on the Circio  

webpage (http://www.circio.com/)